diclofenac ratiopharm 11.6 mg/g geeli
teva b.v. - diclofenac diethylamine - geeli - 11.6 mg/g - diklofenaakki
diclofenac ratiopharm 23.2 mg/g geeli
teva b.v. - diclofenac diethylamine - geeli - 23.2 mg/g - diklofenaakki
steflam appelsiini 8.75 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - flurbiprofen - imeskelytabletti - 8.75 mg - flurbiprofeeni
flurbiprofen reckitt benckiser 8.75 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - flurbiprofen - imeskelytabletti - 8.75 mg - flurbiprofeeni
strefen orange 8.75 mg imeskelytabletti
reckitt benckiser healthcare (scandinavia) a/s - flurbiprofen - imeskelytabletti - 8.75 mg - flurbiprofeeni
ursoferran 200 mg/ml injektioneste, liuos
serumwerk bernburg ag - gleptoferron - injektioneste, liuos - 200 mg/ml - rauta
desloratadine sopharma 0.5 mg/ml oraaliliuos
sopharma ad - desloratadine - oraaliliuos - 0.5 mg/ml - desloratadiini
strefen kirsikka & minttu 16.2 mg/ml sumute suuonteloon, liuos
reckitt benckiser healthcare (scandinavia) a/s - flurbiprofen - sumute suuonteloon, liuos - 16.2 mg/ml - flurbiprofeeni
nobilis ib 4-91
intervet international bv - elävä heikennetty linnun tarttuvan keuhkoputkitulehduksen viruksen varianttikanta 4-91 - immunologiset lääkkeet - kana - kanaalien aktiivinen immunisointi vaihtelevan kantajan ib 4-91 aiheuttaman tarttuvan keuhkoputkitulehduksen hengityselinten vähentämiseksi.
thyrogen
sanofi b.v. - tirotropiini alfa - kilpirauhasen vajaatoiminta - anterior aivolisäkkeen etulohkon hormonit ja analogit, aivolisäkkeen ja hypotalamuksen hormonit sekä analogit - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.